160 related articles for article (PubMed ID: 29520305)
21. Insights into the Binding of Cyclic RGD Peptidomimetics to α
Guzzetti I; Civera M; Vasile F; Arosio D; Tringali C; Piarulli U; Gennari C; Pignataro L; Belvisi L; Potenza D
ChemistryOpen; 2017 Feb; 6(1):128-136. PubMed ID: 28168158
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.
Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N
Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410
[TBL] [Abstract][Full Text] [Related]
23. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
24. Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells.
Fanelli R; Schembri L; Piarulli U; Pinoli M; Rasini E; Paolillo M; Galiazzo MC; Cosentino M; Marino F
Vasc Cell; 2014; 6():11. PubMed ID: 25053992
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand.
Hall ER; Bibby LI; Slack RJ
Biochem Pharmacol; 2016 Oct; 117():88-96. PubMed ID: 27501918
[TBL] [Abstract][Full Text] [Related]
26. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
[TBL] [Abstract][Full Text] [Related]
27. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
28. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
[TBL] [Abstract][Full Text] [Related]
29. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
[TBL] [Abstract][Full Text] [Related]
30. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α
Paulus J; Sewald N
Front Chem; 2022; 10():869639. PubMed ID: 35480387
[TBL] [Abstract][Full Text] [Related]
32. (99m)Tc-HisoDGR as a Potential SPECT Probe for Orthotopic Glioma Detection via Targeting of Integrin α5β1.
Zhao H; Gao H; Zhai L; Liu X; Jia B; Shi J; Wang F
Bioconjug Chem; 2016 May; 27(5):1259-66. PubMed ID: 27098436
[TBL] [Abstract][Full Text] [Related]
33. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.
Monferran S; Skuli N; Delmas C; Favre G; Bonnet J; Cohen-Jonathan-Moyal E; Toulas C
Int J Cancer; 2008 Jul; 123(2):357-364. PubMed ID: 18464290
[TBL] [Abstract][Full Text] [Related]
34. The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines.
Cheng W; Feng F; Ma C; Wang H
Onco Targets Ther; 2016; 9():1415-23. PubMed ID: 27042110
[TBL] [Abstract][Full Text] [Related]
35. Exploring the Role of RGD-Recognizing Integrins in Cancer.
Nieberler M; Reuning U; Reichart F; Notni J; Wester HJ; Schwaiger M; Weinmüller M; Räder A; Steiger K; Kessler H
Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28869579
[TBL] [Abstract][Full Text] [Related]
36. There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography.
Steiger K; Quigley NG; Groll T; Richter F; Zierke MA; Beer AJ; Weichert W; Schwaiger M; Kossatz S; Notni J
EJNMMI Res; 2021 Oct; 11(1):106. PubMed ID: 34636990
[TBL] [Abstract][Full Text] [Related]
37. Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.
Triantafilou K; Triantafilou M; Takada Y; Fernandez N
J Virol; 2000 Jul; 74(13):5856-62. PubMed ID: 10846065
[TBL] [Abstract][Full Text] [Related]
38. Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.
Curnis F; Sacchi A; Gasparri A; Longhi R; Bachi A; Doglioni C; Bordignon C; Traversari C; Rizzardi GP; Corti A
Cancer Res; 2008 Sep; 68(17):7073-82. PubMed ID: 18757422
[TBL] [Abstract][Full Text] [Related]
39. Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to α
Nardelli F; Paissoni C; Quilici G; Gori A; Traversari C; Valentinis B; Sacchi A; Corti A; Curnis F; Ghitti M; Musco G
J Med Chem; 2018 Sep; 61(17):7474-7485. PubMed ID: 29883545
[TBL] [Abstract][Full Text] [Related]
40. Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms.
Mittelbronn M; Warth A; Meyermann R; Goodman S; Weller M
Histol Histopathol; 2013 Jun; 28(6):749-58. PubMed ID: 23238957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
